Ken Page
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Organic Chemistry top 10%
- Synthesis and Biological Evaluation
- Synthesis and biological activity
- Multicomponent Synthesis of Heterocycles
Papers in
-
- Biochemical and Molecular Research 3
- Phosphodiesterase function and regulation 2
- Phenothiazines and Benzothiazines Synthesis and Activities 2
- Oncology 4
- Co-authors
- Richard A. Thompson (2 shared papers)Ian D. Wilson (2 shared papers)Richard Weaver (2 shared papers)J. Gerry Kenna (2 shared papers)Hugues Dolgos (2 shared papers)Emre M. Isin (2 shared papers)Yan Li (2 shared papers)Lars Weidolf (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (12 papers)Sensors and Actuators B Chemical (2 papers)Journal of Medicinal Chemistry (2 papers)Chemico-Biological Interactions (1 paper)Molecular Pharmaceutics (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Ken Page
22 papers receiving 786 citations
Peers
Comparison fields: 5 of 84
- Pharmacology 204
- Organic Chemistry 249
- Oncology 185
- Computational Theory and Mathematics 110
- Hepatology 34
Countries citing papers authored by Ken Page
This map shows the geographic impact of Ken Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Page more than expected).
Fields of papers citing papers by Ken Page
This network shows the impact of papers produced by Ken Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Page. The network helps show where Ken Page may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Page, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 180 | |
| 2 | 2012 | 168 | |
| 3 | 2003 | 140 | |
| 4 | 2010 | 78 | |
| 5 | 2004 | 43 | |
| 6 | 2015 | 42 | |
| 7 | 2008 | 24 | |
| 8 | 2013 | 19 | |
| 9 | 1998 | 18 | |
| 10 | 2015 | 16 | |
| 11 | 2011 | 14 | |
| 12 | 2011 | 13 | |
| 13 | 1998 | 12 | |
| 14 | 2009 | 12 | |
| 15 | 2009 | 10 | |
| 16 | 2015 | 9 | |
| 17 | 1987 | 8 | |
| 18 | 2008 | 7 | |
| 19 | 2017 | 6 | |
| 20 | 2008 | 5 |
About Ken Page
Ken Page is a scholar working on Molecular Biology, Oncology, Pharmacology, Cancer Research and Computational Theory and Mathematics, having authored 23 papers that have together received 829 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Protease and Inhibitor Mechanisms (3 papers), Computational Drug Discovery Methods (3 papers), Analytical Chemistry and Chromatography (3 papers), Biochemical and Molecular Research (3 papers), Phosphodiesterase function and regulation (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). The work is most often cited by research in Pharmacology (204 citations), Organic Chemistry (249 citations), Oncology (185 citations), Computational Theory and Mathematics (110 citations) and Hepatology (34 citations). Ken Page has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Richard A. Thompson, Ian D. Wilson, Richard Weaver, J. Gerry Kenna, Hugues Dolgos, Emre M. Isin, Yan Li, Lars Weidolf, Brian Middleton and Steve Swallow. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Sensors and Actuators B Chemical, Journal of Medicinal Chemistry, Chemico-Biological Interactions and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.